• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肝细胞癌患者接受根治性肝切除术后,肝内转移比多处发生更具风险。

Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection.

作者信息

Kim Jong Man, Kwon Choon Hyuck David, Joh Jae-Won, Park Jae Berm, Lee Joon Hyeok, Kim Sung Joo, Paik Seung Woon, Park Cheol Keun

出版信息

Hepatogastroenterology. 2015 Mar-Apr;62(138):399-404.

PMID:25916071
Abstract

BACKGROUND/AIMS: The characteristics of multiple nudules in hepatocellular carcinomas (HCCs) after curative liver resection remain obscure. We compare the clinicopathologic characteristics and prognoses between patients with hepatic lesions with multicentric occurrence (MO) and intrahepatic metastasis (IM) at the time of surgical resection.

METHODOLOGY

The histopathologic features of multiple tumors from 198 patients of HCC were analyzed and divided into MO group (n = 51, 25.8%) for multicentric HCCs and an IM group (n = 147, 74.2%) in cases with intrahepatic metastases. Overall survival rate, disease-free survival and clinicopathologic differences were compared between the two groups.

RESULTS

Microvascular invasion and increased tumor size were the most important factors discriminating the IM group from the MO group (P < 0.001 and P = 0.027, respectively). Kaplan-Meier and log rank tests revealed that disease-free survival and overall survival rates in the MO group were significantly higher than those for the IM group (P < 0.001 and P < 0.001, respectively). A multivariate analysis of Cox's proportional hazards model showed that increased alpha-fetoprotein (AFP) and protein induced by vitamin K antagonist-II (PIVKA-II) levels, portal vein invasion and intrahepatic metastases were the most important prognostic factors.

CONCLUSIONS

Among HCCs, the prognosis of patients with MO is significantly better than that of patients with IM.

摘要

背景/目的:根治性肝切除术后肝细胞癌(HCC)多发结节的特征仍不清楚。我们比较手术切除时肝内病变多中心发生(MO)和肝内转移(IM)患者的临床病理特征及预后。

方法

分析198例HCC患者多灶肿瘤的组织病理学特征,分为多中心HCC的MO组(n = 51,25.8%)和肝内转移的IM组(n = 147,74.2%)。比较两组的总生存率、无病生存率及临床病理差异。

结果

微血管侵犯和肿瘤大小增加是区分IM组和MO组的最重要因素(分别为P < 0.001和P = 0.027)。Kaplan-Meier法和对数秩检验显示,MO组的无病生存率和总生存率显著高于IM组(分别为P < 0.001和P < 0.001)。Cox比例风险模型多因素分析显示,甲胎蛋白(AFP)和维生素K拮抗剂-II诱导蛋白(PIVKA-II)水平升高、门静脉侵犯和肝内转移是最重要的预后因素。

结论

在HCC中,MO患者的预后明显优于IM患者。

相似文献

1
Intrahepatic metastasis is more risky than multiple occurrence in hepatocellular carcinoma patients after curative liver resection.在肝细胞癌患者接受根治性肝切除术后,肝内转移比多处发生更具风险。
Hepatogastroenterology. 2015 Mar-Apr;62(138):399-404.
2
Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV.与乙肝病毒相关的多中心发生及多灶性肝细胞癌肝内转移的临床病理特征
Surg Oncol. 2009 Mar;18(1):25-30. doi: 10.1016/j.suronc.2008.05.009. Epub 2008 Jul 18.
3
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.术前甲胎蛋白和脱γ-羧基凝血酶原在肝细胞癌患者中的预后作用
World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.
4
Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.伴有门静脉癌栓的晚期肝细胞癌肝切除术后的生存率
World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.
5
Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.甲胎蛋白及维生素K缺乏或拮抗剂-II诱导蛋白在乙型肝炎病毒相关肝细胞癌中的预后价值:一项前瞻性研究
J Clin Gastroenterol. 2009 May-Jun;43(5):482-8. doi: 10.1097/MCG.0b013e318182015a.
6
Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients.同步多结节肝细胞癌患者多中心发生及肝内转移的临床病理特征与预后
Asian Pac J Cancer Prev. 2013;14(1):217-23. doi: 10.7314/apjcp.2013.14.1.217.
7
Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.改良顺铂经动脉化疗栓塞术治疗大肝细胞癌:163例患者队列中肿瘤反应和生存预测因素的多变量分析
J Vasc Interv Radiol. 2013 Nov;24(11):1639-46. doi: 10.1016/j.jvir.2013.06.017. Epub 2013 Aug 17.
8
Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma.射波刀治疗晚期肝细胞癌
World J Gastroenterol. 2015 Dec 14;21(46):13101-12. doi: 10.3748/wjg.v21.i46.13101.
9
Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.中国单中心经验:复发性肝细胞癌患者再次肝切除的长期结果及复发类型分析和其预后。
Ann Surg Oncol. 2012 Aug;19(8):2515-25. doi: 10.1245/s10434-012-2269-7. Epub 2012 Mar 7.
10
Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.肝细胞癌初次肝切除术后一年内复发的临床病理危险因素。
Am Surg. 2011 May;77(5):572-8.

引用本文的文献

1
Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma.转录组分析为管理复发性肝细胞癌开创了精准医学的新时代。
World J Gastroenterol. 2023 Feb 7;29(5):780-799. doi: 10.3748/wjg.v29.i5.780.
2
The Endless Sources of Hepatocellular Carcinoma Heterogeneity.肝细胞癌异质性的无尽来源
Cancers (Basel). 2021 May 26;13(11):2621. doi: 10.3390/cancers13112621.
3
Impact of low skeletal muscle mass index and perioperative blood transfusion on the prognosis for HCC following curative resection.
低骨骼肌质量指数和围手术期输血对肝癌根治性切除术后预后的影响。
BMC Gastroenterol. 2020 Oct 7;20(1):328. doi: 10.1186/s12876-020-01472-z.
4
Liver Resection Is Justified in Patients with BCLC Intermediate Stage Hepatocellular Carcinoma without Microvascular Invasion.BCLC 中期无微血管侵犯肝细胞癌患者行肝切除术是合理的。
J Gastrointest Surg. 2020 Dec;24(12):2737-2747. doi: 10.1007/s11605-019-04251-8. Epub 2019 Nov 25.
5
Does microvascular invasion in Barcelona Clinic Liver Cancer stage A multinodular hepatocellular carcinoma indicate early-stage behavior?巴塞罗那临床肝癌分期A期多结节肝细胞癌中的微血管侵犯是否提示早期行为?
Ann Transl Med. 2019 Sep;7(18):428. doi: 10.21037/atm.2019.08.114.
6
Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications.鉴定多灶性肝细胞癌的克隆起源及其临床意义。
Clin Transl Gastroenterol. 2019 Feb;10(2):e00006. doi: 10.14309/ctg.0000000000000006.
7
Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.巴塞罗那临床肝癌早期伴微血管侵犯的多结节肝细胞癌术后辅助经动脉化疗栓塞术
Hepatobiliary Surg Nutr. 2018 Dec;7(6):418-428. doi: 10.21037/hbsn.2018.09.05.